Fig. 1. (A) Mean Eczema Area and Severity Index (EASI) and (B) mean Dermatology Life Quality Index (DLQI) scores after dupilumab treatment in atopic dermatitis patients. Values are presented as mean±standard error (baseline, n=26; visit 2, n=26; visit 3, n=23; visit 4, n=5; visit 5, n=1). (C) Percentage of patients achieving EASI50, EASI75, EASI90, and DLQI minimal clinically important difference (MCID) after dupilumab treatment in atopic dermatitis patients. Mean values are indicated. *p<0.05 (vs. baseline) by paired t-test or Wilcoxon signed-rank test.
